Natco Pharma Ltd

Natco Pharma | 524816

Live

₹984.90

+₹23.27 (+2.42%)

As on 10/07/26, 2:58 PM

Market Cap17,223.21 CR

Current Price₹984.9

High / Low₹1,226.8 / 789

PE Ratio7.57

Book Value₹424.97

Dividend Yield0.75%

ROCE32.48%

ROE28.63%

Face Value₹2.00

Current Vol.5,64,963

Average Vol.---

ISININE987B01026

PB Ratio1.88

Debt to Equity0.05

Net Profit Margin42.52

Operating Margin57.58

Share Price Chart - Natco Pharma Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹961.6₹965

₹984.9

Previous CloseToday's Open

₹789₹1,226.8

₹984.9

52W Low52W High

₹965Today's Open

₹961.6Previous Close

5,64,963Volume

₹78952W Low

₹1,226.852W High

Ratios

No data available

About Company

Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company as 'Natco Fine Pharmaceuticals Private Limited'
The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation dated 30 December 1994 issued by the RoC, Andhra Pradesh
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs)
The Company's focus is primarily on niche therapeutic areas and complex products
It sells products in over 40 countries
FDF products are sold in the United States, India, Europe and the rest of the world (RoW)
Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA
In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides
In 1988, the company inaugurated a Parenterals manufacturing facility at Nagarajuna Sagar, Telangana
In 1993, the company inaugurated its chemical division at Mekaguda, Telangana

Ethics: Natco Pharma Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI54.30

SMA 20905.31

SMA 501012.54

SMA 1001000.47

SMA 200928.76

SMA 10939.06

MACD_12_26_Days-5.77

EMA10Day941.43

EMA20Day936.92

EMA50Day969.70

MACD_12_26_9_Days15.75

EMA100Day975.02

EMA200Day970.81

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth10.77%

ROE27.98%

EBITDA Margin57.58%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	4,429.50	3,998.80	2,707.10	1,944.80	2,052.10
Interest	23.90	19.20	14.50	17.70	13.30
Expenses	2,233.50	2,247.40	1,771.50	1,681.30	1,445.90
Financing Profit	2,550.50	1,879.50	1,040.20	362.50	709.80
Financing Margin %	58%	47%	38%	19%	35%
Other Income	354.50	128.10	104.60	99.00	103.60
Depreciation	235.20	186.80	163.80	142.60	116.90
Profit before tax	2,291.40	1,673.50	861.90	202.20	579.60
Tax %	18%	17%	17%	16%	24%
Net Profit	1,883.40	1,388.30	715.30	170.00	442.40
EPS in Rs	105.26	77.34	39.18	9.32	24.20

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	1,88,347	₹605.8	59.01%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	1,88,347	₹605.8	59.01%
ISHARES INDIA SC MAURITIUS COMPANY	03 Oct ‘22	Sell	22,213	₹605.8	6.96%
ISHARES MSCI INDIA SMALL-CAP ETF	03 Oct ‘22	Purchase	22,213	₹605.8	6.96%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

18 Feb 2026

Interim 3 Dividend (₹1.5)

Declared third interim dividend of Rs. 1.50/- (Rupees one and fifty paise only) ( 75 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2025-26. The date for taking on record of its shareholders eligible for the purpose of payment of third interim dividend i.e., record date is fixed as Wednesday, the 18th February, 2026. The payment of said interim dividend will start from 26th February, 2026.

12 Feb 2026

20 Nov 2025

Interim 2 Dividend (₹1.5)

Board of Directors of the Company at their meeting held today have considered and approved the following along with other items of business: Declared second interim dividend of Rs.1.50 (Rupees one and fifty paise only) (75%) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2025-26. The date for taking on record of its shareholders eligible for the purpose of payment ofsecond interim dividend i.e., record date is fixed as Thursday, the 20th day of November 2025. The payment of said interim dividend will start from November 28, 2025.

14 Nov 2025

25 Sept 2025

AGM

28 Aug 2025

19 Aug 2025

Interim 1 Dividend (₹2)

Declared interim dividend of Rs.2/- (Rupees Two only) (100 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2025-26. The date for taking on record of its shareholders is eligible for the purpose of payment of interim dividend i.e., record date is fixed as Tuesday, the day of 19 th August 2025. The payment of said interim dividend will start from 26th August 2025.

12 Aug 2025

18 Feb 2025

Interim 3 Dividend (₹1.5)

Declared third interim dividend of Rs. 1.50/- (Rupees One and Paise fifty only) (75 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2024-25. The date for taking on record of its shareholders eligible for the purpose of payment of third interim dividend i.e., record date is fixed as Tuesday, the 18th February, 2025. The payment of said interim dividend will start from 28th February, 2025.

12 Feb 2025

27 Nov 2024

Interim 2 Dividend (₹1.5)

Outcome of Board Meeting Declared second interim dividend of Rs.1.50 (Rupees one and fifty paise only) (75%) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2024-25. The date for taking on record of its shareholders eligible for the purpose of payment ofsecond interim dividend i.e., record date is fixed as Monday, the 25th day of November 2024. The payment of said interim dividend will start from 2nd December 2024. The Board of Directors vide circular Resolution dated November 13, 2024 have revised the Record Date as 27th November, 2024 for ascertaining the shareholders eligible for making payment of second Interim Dividend of Rs.1.50 (Rupee one and fifty paise only) which was declared by the Board of Director at their meeting held on November 12, 2024 The payment of said interim dividend will start from 4th December 2024 (As Per BSE Announcement dated on 13.11.2024)

12 Nov 2024

30 Sept 2024

AGM

12 Aug 2024

23 Aug 2024

Interim Dividend (₹3)

Board Meeting Outcome for Outcome Of Board Meeting Declared interim dividend of Rs.3.00/- (Rupees Three Rupees only) (150%) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2024-25. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend i.e., record date is fixed as Friday, the 23rd day of August, 2024. The payment of said interim dividend will start from 30th August, 2024.

12 Aug 2024

26 Feb 2024

Interim 3 Dividend (₹1.25)

outcome of Board Meeting

14 Feb 2024

24 Nov 2023

Interim 2 Dividend (₹1.25)

Outcome of the Board Meeting Declared second interim dividend of Rs.1.25 (Rupees one and twenty five paise only) (62.50 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment ofsecond interim dividend i.e.,record date is fixed as Friday, the 24th day of November 2023. The payment of said interim dividend will start from 1st December 2023.

14 Nov 2023

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
961	17,221	12	2	11	0	42.52%
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,437-40 (-0.3%)

Frequently Asked Questions

What is Share Price of Natco Pharma Ltd?

The current share price of Natco Pharma Ltd (Natco Pharma) is ₹984.90. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Natco Pharma Ltd?

The Price-to-Earnings (P/E) ratio of Natco Pharma Ltd is 984.90. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Natco Pharma Ltd?

Natco Pharma Ltd has a 52-week high of ₹1226.80 and a 52-week low of ₹789.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Natco Pharma Ltd?

Natco Pharma Ltd offers a dividend yield of 0.52%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Natco Pharma Ltd?

The Earnings Per Share (EPS) of Natco Pharma Ltd is ₹79.20. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Natco Pharma Ltd?

Natco Pharma Ltd has a Return on Equity (ROE) of 28.63%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video